These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2623135)

  • 21. Failure of plasma norepinephrine to consistently reflect sympathetic activity in humans.
    Floras J; Vann Jones J; Hassan MO; Osikowska BA; Sever PS; Sleight P
    Hypertension; 1986 Aug; 8(8):641-9. PubMed ID: 3733213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Relation between cardiac sympathetic activity and hypertensive left ventricular hypertrophy.
    Schlaich MP; Kaye DM; Lambert E; Sommerville M; Socratous F; Esler MD
    Circulation; 2003 Aug; 108(5):560-5. PubMed ID: 12847071
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sympathetic nervous function in human heart as assessed by cardiac spillovers of dihydroxyphenylglycol and norepinephrine.
    Eisenhofer G; Esler MD; Meredith IT; Dart A; Cannon RO; Quyyumi AA; Lambert G; Chin J; Jennings GL; Goldstein DS
    Circulation; 1992 May; 85(5):1775-85. PubMed ID: 1572033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute and chronic calcium antagonist treatment elevates sympathetic activity in primary hypertension.
    Lindqvist M; Kahan T; Melcher A; Hjemdahl P
    Hypertension; 1994 Sep; 24(3):287-96. PubMed ID: 8082934
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A test of the "epinephrine hypothesis" in humans.
    Goldstein DS; Golczynska A; Stuhlmuller J; Holmes C; Rea RF; Grossman E; Lenders J
    Hypertension; 1999 Jan; 33(1):36-43. PubMed ID: 9931079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasma norepinephrine pharmacokinetics during mental challenge.
    Goldstein DS; Eisenhofer G; Sax FL; Keiser HR; Kopin IJ
    Psychosom Med; 1987; 49(6):591-605. PubMed ID: 2827219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac sympathetic denervation in Parkinson disease.
    Goldstein DS; Holmes C; Li ST; Bruce S; Metman LV; Cannon RO
    Ann Intern Med; 2000 Sep; 133(5):338-47. PubMed ID: 10979878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Angiotensin II and sympathetic activity in patients with congestive heart failure.
    Goldsmith SR; Hasking GJ; Miller E
    J Am Coll Cardiol; 1993 Apr; 21(5):1107-13. PubMed ID: 8384645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiac sympathetic nervous activity in congestive heart failure. Evidence for increased neuronal norepinephrine release and preserved neuronal uptake.
    Meredith IT; Eisenhofer G; Lambert GW; Dewar EM; Jennings GL; Esler MD
    Circulation; 1993 Jul; 88(1):136-45. PubMed ID: 8391399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity.
    Hasking GJ; Esler MD; Jennings GL; Burton D; Johns JA; Korner PI
    Circulation; 1986 Apr; 73(4):615-21. PubMed ID: 3948363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The sympathetic system and hypertension.
    Esler M
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):99S-105S. PubMed ID: 10921528
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increased cardiac adrenergic drive precedes generalized sympathetic activation in human heart failure.
    Rundqvist B; Elam M; Bergmann-Sverrisdottir Y; Eisenhofer G; Friberg P
    Circulation; 1997 Jan; 95(1):169-75. PubMed ID: 8994433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Digoxin reduces cardiac sympathetic activity in severe congestive heart failure.
    Newton GE; Tong JH; Schofield AM; Baines AD; Floras JS; Parker JD
    J Am Coll Cardiol; 1996 Jul; 28(1):155-61. PubMed ID: 8752808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aging effects on human sympathetic neuronal function.
    Esler MD; Turner AG; Kaye DM; Thompson JM; Kingwell BA; Morris M; Lambert GW; Jennings GL; Cox HS; Seals DR
    Am J Physiol; 1995 Jan; 268(1 Pt 2):R278-85. PubMed ID: 7840332
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanism of elevated plasma noradrenaline in the course of essential hypertension.
    Esler M; Jennings G; Biviano B; Lambert G; Hasking G
    J Cardiovasc Pharmacol; 1986; 8 Suppl 5():S39-43. PubMed ID: 2427882
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exercise training lowers resting renal but not cardiac sympathetic activity in humans.
    Meredith IT; Friberg P; Jennings GL; Dewar EM; Fazio VA; Lambert GW; Esler MD
    Hypertension; 1991 Nov; 18(5):575-82. PubMed ID: 1937659
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impaired sympathetic nervous system response to cognitive effort in early Alzheimer's disease.
    Borson S; Barnes RF; Veith RC; Halter JB; Raskind MA
    J Gerontol; 1989 Jan; 44(1):M8-12. PubMed ID: 2910990
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The sympathetic nervous system in the pathogenesis of hypertension.
    Rahn KH; Barenbrock M; Hausberg M
    J Hypertens Suppl; 1999 Aug; 17(3):S11-4. PubMed ID: 10489093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Individual differences in cardiac sympathetic control predict endocrine and immune responses to acute psychological stress.
    Uchino BN; Cacioppo JT; Malarkey W; Glaser R
    J Pers Soc Psychol; 1995 Oct; 69(4):736-43. PubMed ID: 7473028
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Yohimbine increases sympathetic nerve activity and norepinephrine spillover in normal volunteers.
    Grossman E; Rea RF; Hoffman A; Goldstein DS
    Am J Physiol; 1991 Jan; 260(1 Pt 2):R142-7. PubMed ID: 1847020
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.